Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells

References

• Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117:5019–5032.
   PubMed Web of Science ®Google Scholar
• Hoelzer D, Walewski J, Dohner H, et al. Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood. 2014;124:3870–3879.
   PubMed Web of Science ®Google Scholar
• Thomas DA, Faderl S, O'Brien S, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106:1569–1580.
   PubMed Web of Science ®Google Scholar
• Rizzieri DA, Johnson JL, Byrd JC, et al. Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002. Br J Haematol. 2014;165:102–111.
   PubMed Web of Science ®Google Scholar
• Dyshlovoy SA, Honecker F. Marine compounds and cancer: where do we stand?. Mar Drugs. 2015;13:5657–5665.
   PubMed Web of Science ®Google Scholar
• Stonik V. Marine natural products: a way to new drugs. Acta Naturae. 2009;1:15–25.
   PubMed Web of Science ®Google Scholar
• Girard M, Bélanger J, ApSimon JW, et al. Frondoside A. A novel triterpene glycoside from the holothurian Cucumaria frondosa. Can J Chem. 1990;68:11–18.
   Web of Science ®Google Scholar
• Aminin D, Menchinskaya E, Pisliagin E, et al. Anticancer activity of sea cucumber triterpene glycosides. Marine Drugs. 2015;13:1202–1223.
   PubMed Web of Science ®Google Scholar
• Dyshlovoy SA, Menchinskaya ES, Venz S, et al. The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer. Int J Cancer. 2016;138:2450–2465.
   PubMed Web of Science ®Google Scholar
• Doucet JP, Hussain A, Al-Rasheed M, et al. Differences in the expression of apoptotic proteins in Burkitt's lymphoma cell lines: potential models for screening apoptosis-inducing agents. Leuk Lymphoma. 2004;45:357–362.
   PubMed Web of Science ®Google Scholar
• Silchenko AS, Avilov SA, Kalinin VI, et al. Constituents of the sea cucumber Cucumaria okhotensis. Structures of okhotosides B1-B3 and cytotoxic activities of some glycosides from this species. J Nat Prod. 2008;71:351–356.
   PubMed Web of Science ®Google Scholar
• Barltrop JA, Owen TC, Cory AH, et al. 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans as cell-viability indicators. Bioorg Med Chem Lett. 1991;1:611–614.
   Web of Science ®Google Scholar
• Dyshlovoy SA, Fedorov SN, Kalinovsky AI, et al. Mycalamide A shows cytotoxic properties and prevents EGF-induced neoplastic transformation through inhibition of nuclear factors. Marine Drugs. 2012;10:1212–1224.
   PubMed Web of Science ®Google Scholar
• Dyshlovoy SA, Naeth I, Venz S, et al. Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity. J Proteome Res. 2012;11:2316–2330.
   PubMed Web of Science ®Google Scholar
• Dyshlovoy SA, Hauschild J, Amann K, et al. Marine alkaloid Monanchocidin A overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization. Oncotarget. 2015;6:17328–17341.
   PubMed Web of Science ®Google Scholar
• Dyshlovoy SA, Otte K, Alsdorf WH, et al. Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancer. Oncotarget. 2016;7:69703–69717.
   PubMed Web of Science ®Google Scholar
• Pelageev DN, Dyshlovoy SA, Pokhilo ND, et al. Quinone-carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: synthesis and determination of in vitro activity. Eur J Med Chem. 2014;77:139–144.
   PubMed Web of Science ®Google Scholar
• Dyshlovoy SA, Tabakmakher KM, Hauschild J, et al. Guanidine alkaloids from the marine sponge monanchora pulchra show cytotoxic properties and prevent EGF-induced neoplastic transformation in vitro. Mar Drugs. 2016;14:133.
   PubMed Web of Science ®Google Scholar
• Philchenkov A, Zavelevich M, Kroczak TJ, et al. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol. 2004;26:82–97.
   PubMed Web of Science ®Google Scholar
• Zyada MM. Relationship of survivin to clinical drug resistance in Burkitt's lymphoma of the head and neck region. Med Oncol. 2011;28:1565–1569.
   PubMed Web of Science ®Google Scholar
• Tait SW, Green DR. Caspase-independent cell death: leaving the set without the final cut. Oncogene. 2008;27:6452–6461.
   PubMed Web of Science ®Google Scholar
• Bröker LE, Kruyt FAE, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res. 2005;11:3155–3162.
   PubMed Web of Science ®Google Scholar
• Lorenzo HK, Susin SA, Penninger J, et al. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ. 1999;6:516–524.
   PubMed Web of Science ®Google Scholar
• Sevrioukova IF. Apoptosis-inducing factor: structure, function, and redox regulation. Antioxid Redox Signal. 2011;14:2545–2579.
   PubMed Web of Science ®Google Scholar
• Li X, Fang P, Mai J, et al. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol. 2013;6:19.
   PubMed Web of Science ®Google Scholar
• Nagy N, Takahara M, Nishikawa J, et al. Wild-type p53 activates SAP expression in lymphoid cells. Oncogene. 2004;23:8563–8570.
   PubMed Web of Science ®Google Scholar
• O'Connor PM, Jackman J, Jondle D, et al. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 1993;53:4776–4780.
   PubMed Web of Science ®Google Scholar
• Farrell PJ, Allan GJ, Shanahan F, et al. p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J. 1991;10:2879–2887.
   PubMed Web of Science ®Google Scholar
• Komarov PG, Komarova EA, Kondratov RV, et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 1999;285:1733–1737.
   PubMed Web of Science ®Google Scholar
• Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55.
   PubMedGoogle Scholar
• Yang ZJ, Chee CE, Huang S, et al. The role of autophagy in cancer: therapeutic implications. Molecul Cancer Thera. 2011;10:1533–1541.
   PubMed Web of Science ®Google Scholar
• Ojha R, Singh SK, Bhattacharyya S, et al. Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent. J Urol. 2014;191:1889–1898.
   PubMed Web of Science ®Google Scholar
• Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer. 2007;7:961–967.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1–222.
   PubMed Web of Science ®Google Scholar
• Magluta EPS, Klumb CE. Resistência ao tratamento no linfoma de Burkitt: associação com mutações específicas no gene TP53? Rev Bras Hematol Hemoter. 2008;30:41–46.
   Google Scholar
• Lindstrom MS, Klangby U, Wiman KG. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53. Oncogene. 2001;20:2171–2177.
   PubMed Web of Science ®Google Scholar
• Ichikawa A, Kinoshita T, Watanabe T, et al. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med. 1997;337:529–534.
   PubMed Web of Science ®Google Scholar
• Yu Q. Restoring p53-mediated apoptosis in cancer cells: new opportunities for cancer therapy. Drug Resist Updat. 2006;9:19–25.
   PubMed Web of Science ®Google Scholar
• Erdal H, Berndtsson M, Castro J, et al. Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA. 2005;102:192–197.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med. 2005;11:725–730.
   PubMed Web of Science ®Google Scholar
• Chipuk JE, Green DR. Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol. 2005;6:268–275.
   PubMed Web of Science ®Google Scholar
• Sui X, Chen R, Wang Z, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013;4:e838.
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Yu D, Lum JJ, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest. 117:326–336.
   PubMed Web of Science ®Google Scholar